Adma Biologics reported $376K in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Adma Biologics USD 376K 24K Sep/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Dynavax Technologies USD 6.8M 941K Jun/2025
Takeda JPY 87.87B 43.48B Dec/2025